Additional file 1 of Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model

Additional file 1: Fig. S1. Lmean rank of the five SM models and CAFs immunochemistry. Table S1. Percentage of CAFs and tumors receiving ≥10 % of the maximum Dabs within the SM model of the five models using either tumors and CAFs as sources for 177Lu and 225Ac. Fig. S2. Mean Dabs within the SM model of the five models using either tumors (brown) and CAFs (violet) as sources for 177Lu (dashed) and 225Ac (solid)